Видео ютуба по тегу Matthew Ulrickson Md

ОСТРЫЙ ЛЕЙКОЗ, Мэтью Ульриксон, доктор медицины, 4/2019
ОСТРЫЙ ЛЕЙКОЗ, Мэтью Ульриксон, доктор медицины, 4/2019
Zamtocabtagene autoleucel: mechanism of production & potential implications for access
Zamtocabtagene autoleucel: mechanism of production & potential implications for access
The changing role of alloSCT in DLBCL in the era of novel agents
The changing role of alloSCT in DLBCL in the era of novel agents
Optimizing CAR-T outcomes in DLBCL: possible combination strategies & sequencing of agents
Optimizing CAR-T outcomes in DLBCL: possible combination strategies & sequencing of agents
Zamtocabtagene autoleucel for the treatment of patients with R/R DLBCL
Zamtocabtagene autoleucel for the treatment of patients with R/R DLBCL
New immunotherapy for multiple myeloma shows promising results
New immunotherapy for multiple myeloma shows promising results
31.10.25 — Оптимизация лечения меланомы с помощью новых биомаркеров
31.10.25 — Оптимизация лечения меланомы с помощью новых биомаркеров
Unmet needs and current perspectives in high-risk MCL
Unmet needs and current perspectives in high-risk MCL
Personalized & Precision Medicine (PPM) in Oncology | Sergey Suchkov | Cancer-2025
Personalized & Precision Medicine (PPM) in Oncology | Sergey Suchkov | Cancer-2025
Тромбы при #MDS: Луспатерцепт против эритропоэтинстимулирующих препаратов | Нихил Войяла, доктор ...
Тромбы при #MDS: Луспатерцепт против эритропоэтинстимулирующих препаратов | Нихил Войяла, доктор ...
Molecular Work-Up and Therapeutic Targeting of H3K27M-Diffuse Midline Glioma with Dr Carl Koschmann
Molecular Work-Up and Therapeutic Targeting of H3K27M-Diffuse Midline Glioma with Dr Carl Koschmann
Training Tomorrow’s Researchers: Students Shaping the Future of Cancer Care
Training Tomorrow’s Researchers: Students Shaping the Future of Cancer Care
"Liquid Biopsy: The Key to Unlocking a New Era of Precision Oncology" by Jacob Berchuck, MD
Dr. Mateo Mejia Saldarriaga: Biomarker Predicts Response to CAR T-Cell Therapy in Multiple Myeloma
Dr. Mateo Mejia Saldarriaga: Biomarker Predicts Response to CAR T-Cell Therapy in Multiple Myeloma
Cxbladder Triage Inclusion in 2025 Microhematuria: AUA/SUFU Guideline
Cxbladder Triage Inclusion in 2025 Microhematuria: AUA/SUFU Guideline